Objective. To examine racial disparities associated with breast cancer treatment and survival
in elderly patients with early stage operable breast cancer. Methods. We studied 23,110 …

Purpose Black women with breast cancer are known to have poorer survival than white
women. Suboptimal treatment may compromise the survival benefits of adjuvant …

While large differences by race/ethnicity in breast cancer survival are well established, it is
unknown whether differences in quality of chemotherapy delivered explain the racial/ethnic …

PURPOSE: We sought to examine tumor subtype, stage at diagnosis, time to surgery (TTS),
and overall survival (OS) among Hispanic patients of different races and among Hispanic …

BACKGROUND African‐American women have a significantly worse prognosis from breast
carcinoma compared with white women, even when the stage at diagnosis is equivalent …

Recent breast cancer treatment studies conducted in large urban settings have reported
racial disparities in the appropriate use of adjuvant chemotherapy. This article presents the …

Background The disparity in breast cancer mortality between African American women and
non-Hispanic white women has been the subject of increased scrutiny. Few studies have …

Background Black patients with breast cancer may be at greater risk for chemotherapy-
related hematologic toxicity than white patients because of lower baseline blood cell counts …

This review explores factors potentially contributing to the disparity in survival after breast
cancer between African‐American and Caucasian women in the United States. A number of …

Purpose We conducted a systematic review and meta-analysis to measure the extent to
which race is associated with delayed initiation or receipt of inadequate chemotherapy …